• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ProPhase Labs Inc

+ Add to Watchlist

PRPH:US

1.5400 USD 0.0201 1.29%

As of 20:10:00 ET on 07/30/2014.

Snapshot for ProPhase Labs Inc (PRPH)

Open: 1.5500 Day's Range: 1.5100 - 1.5941 Volume: 19,307
Previous Close: 1.5601 52wk Range: 1.4900 - 2.9800 1-Yr Rtn: -0.65%

Stock Chart for PRPH

No chart data available.
  • PRPH:US 1.5400
  • 1D
  • 1M
  • 1Y
1.5601
Interactive PRPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PRPH

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0400
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 25.87
Shares Outstanding (M) 16.80
30 Day Average Volume 157,983
Price/Book (mrq) 2.0040
Price/Sale (ttm) 1.0432
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PRPH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PRPH

ProPhase Labs, Inc. manufactures zinc gluconate glycine lozenges and homeopathic gum. The Company's products reduce the duration and severity of common cold symptoms. ProPhase also manufactures nutrition and weight management products.

Ted KarkusChairman/CEORobert V Cuddihy JrExec VP/CFO/COO
More Company Profile & Key Executives for PRPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil